Lupus Anticoagulant Diagnostic Interpretive Panel
Test Mnemonic
LUPUSP
CPT Codes
- 85670 - QTY (1)
- 86147 - QTY (3)
- 85610 - QTY (1)
- 85390 - QTY (1)
- 86146 - QTY (2)
- 85520 - QTY (1)
- 85730 - QTY (1)
- 85730 - QTY (1)
Aliases
- Lupus Anticoag Panel
Performing Laboratory
Cleveland Clinic Laboratories
Specimen Requirements
Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
---|---|---|---|---|---|
1 mL | Serum | SST (Gold) | Frozen | ||
5 mL | Plasma | Sodium citrate (Lt. Blue) | Frozen | Indicate each tube as serum or plasma. |
Minimum Specimen Requirements
Volume | Type | Container | Collect Temperature | Transport Temperature | Special Instructions |
---|---|---|---|---|---|
0.2 mL | Serum | ||||
2.5 mL | Plasma |
Stability
Environmental Condition | Description |
---|---|
Ambient | 4 hours |
Refrigerated | Unacceptable |
Frozen | 2 months (plasma) |
Days Performed
Mon - Fri
Turnaround Time
3 - 5 days
Methodology
Name | Description |
---|---|
Refer to individual components |
Reference Range
Special Info
3.2% sodium citrate is the preferred anticoagulant recommended by NCCLS. Patient preparation: Discontinue heparin therapy for 2 days prior to collection. If tests are abnormal, the following tests may be ordered and billed: DRVVT (85613), Platelet Neutralization (85597), Staclot (85730,85732), PTT Mixing Study (85730), Factor II (85210), Factor V (85220), Factor X (85260), Factor VIII (85247), Von Willebrand Factor Antigen (85246), Ristocetin Co-factor (85245), Factor IX Assay (85250), Factor XI Assay (85270), Factor XII Assay (85280), Heparin FXa inhibition (85520), Reptilase Time (85635), D-Dimer (85379), & Fibrinogen Ag (85385), Fibrinogen (85384), Bethesda Assay (85335) and Factor VIII Chromogenic (85240). Sample must be accompanied by the completed Clinical History Form for Hemostasis and Thrombosis Evaluation.
Clinical Info
Evaluation of acquired hypercoagulable states and detection of Lupus anticoagulant and Antiphospholipid antibodies